Article Name Medical Finance

Verdane Invests in Clue to Accelerate Future of Women’s Health

The investment - which is a substantial contribution from Verdane's €2 billion growth fund - is the single largest investment in Clue

15th January, 2026


Abyrx and Kairuku $450M Deal Forms New MedEdge Surgical Platform

ew capital dedicated to acquiring commercial-stage surgical product companies. The investment will be managed within MedEdge Holdings LLC. This newly formed holding company will use its ownership of Abyrx and Kairuku as the foundation for a broader growth strategy.

26th November, 2025


Scientific Industries Launches AI-Powered Upgrade for VIVID WORKSTATION

Net revenues rose 52.2 per cent to $1,404,000, driven by strong VIVID product demand within the Torbal Division

20th November, 2025


New analysis highlights urgent need to increase adaptation finance for health

Only 0.5% of multilateral climate finance goes to health, despite climate change projected to cause up to 15.6 millions deaths by 2050.

11th November, 2025


Henry Schein Medical Expands SolutionsHub with Colaborate

Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities

10th September, 2025


ProVerum Secures $80 Mn Series B Financing to Advance New Treatment for BPH

The ProVee System uses a nitinol stent designed to gently reshape the enlarged BPH prostate and alleviate the associated lower urinary tract symptoms

25th August, 2025


Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022 The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal The Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidity

13th August, 2025


AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance

Diagnostic imaging leads revenue surge; Novena centre expands reach in preventive healthcare

13th August, 2025


Conformal Medical Raises $32M to Advance Next-Gen Stroke Prevention Device

Funding boost to support pivotal trial and pre-commercialization of CLAAS® AcuFORM™ LAAO system.

13th August, 2025


RIVANNA Secures $9.92M BARDA Funding to Fast-Track AI-Powered Fracture Detection System

With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.

31st July, 2025


Aptitude Medical Secures $9M BARDA Partnership to Advance Rapid Filovirus Diagnostic for Ebola and Marburg Detection

New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness.

29th July, 2025


Olympus Forms Strategic Partnership to Advance GI Robotics Innovation

Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care.

25th July, 2025


HealthKois Debuts with $300 Million Fund to Drive Scalable Healthcare Innovation in India

The platform sets out to transform India’s healthcare system by investing in high-impact solutions focused on access, affordability, and digital advancement.

06th June, 2025


Sequana Medical Secures €6.3M Convertible Funding to Advance alfapump® Therapy for Liver Disease

SFPIM and Existing Shareholders Back Strategic Funding to Support Liver Disease Therapy Advancements.

27th May, 2025


Koning Health Partners with Sage Tap Poder to Advance Global Adoption of Koning Breast CT

New investment to accelerate global rollout of Koning’s 3D breast imaging technology.

23rd May, 2025


BiaCure Therapies Secures SBIR Phase I Grant to Advance Non-Invasive Fungal Nail Treatment

Innovative high-frequency energy technology aims to revolutionize onychomycosis care with a drug-free, patient-friendly solution.

16th May, 2025


EDGe Surgical Secures $1.3M+ to Drive Growth and Product Expansion

Funding to Fuel Commercial Scale-Up and Launch of New Ortho EDG Surgical Instruments in U.S. and International Markets.

12th May, 2025


AutoIVF Announces Syndicated Investment Round, Led by Vitrolife AB (publ)

Vitrolife AB Leads Syndicated Funding to Accelerate Development of AutoIVF’s Automated In Vitro Fertilization Platform

12th May, 2025


Medtech Special

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer